539 related articles for article (PubMed ID: 27528101)
1. Long-term exposure and safety of lacosamide monotherapy for the treatment of partial-onset (focal) seizures: Results from a multicenter, open-label trial.
Vossler DG; Wechsler RT; Williams P; Byrnes W; Therriault S;
Epilepsia; 2016 Oct; 57(10):1625-1633. PubMed ID: 27528101
[TBL] [Abstract][Full Text] [Related]
2. Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a Phase III open-label extension trial.
Husain A; Chung S; Faught E; Isojarvi J; McShea C; Doty P
Epilepsia; 2012 Mar; 53(3):521-8. PubMed ID: 22372628
[TBL] [Abstract][Full Text] [Related]
3. A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: The VITOBA study.
Runge U; Arnold S; Brandt C; Reinhardt F; Kühn F; Isensee K; Ramirez F; Dedeken P; Lauterbach T; Noack-Rink M; Mayer T
Epilepsia; 2015 Dec; 56(12):1921-30. PubMed ID: 26526971
[TBL] [Abstract][Full Text] [Related]
4. Conversion to lacosamide monotherapy in the treatment of focal epilepsy: results from a historical-controlled, multicenter, double-blind study.
Wechsler RT; Li G; French J; O'Brien TJ; D'Cruz O; Williams P; Goodson R; Brock M;
Epilepsia; 2014 Jul; 55(7):1088-98. PubMed ID: 24915838
[TBL] [Abstract][Full Text] [Related]
5. Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials.
Biton V; Gil-Nagel A; Isojarvi J; Doty P; Hebert D; Fountain NB
Epilepsy Behav; 2015 Nov; 52(Pt A):119-27. PubMed ID: 26414341
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of lacosamide as first add-on or later adjunctive treatment for uncontrolled partial-onset seizures: A multicentre open-label trial.
Zadeh WW; Escartin A; Byrnes W; Tennigkeit F; Borghs S; Li T; Dedeken P; De Backer M;
Seizure; 2015 Sep; 31():72-9. PubMed ID: 26362380
[TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy and safety of lacosamide monotherapy in the treatment of partial-onset seizures: A multicenter evaluation.
Giráldez BG; Toledano R; García-Morales I; Gil-Nagel A; López-González FJ; Tortosa D; Ojeda J; Serratosa JM
Seizure; 2015 Jul; 29():119-22. PubMed ID: 26076854
[TBL] [Abstract][Full Text] [Related]
8. Adjunctive lacosamide--5 years' clinical experience.
Stephen LJ; Kelly K; Parker P; Brodie MJ
Epilepsy Res; 2014 Oct; 108(8):1385-91. PubMed ID: 25064538
[TBL] [Abstract][Full Text] [Related]
9. Adjunctive lacosamide in clinical practice: sodium blockade with a difference?
Stephen LJ; Kelly K; Parker P; Brodie MJ
Epilepsy Behav; 2011 Nov; 22(3):499-504. PubMed ID: 21890421
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of adjunctive lacosamide in Chinese and Japanese adults with epilepsy and focal seizures: A long-term, open-label extension of a randomized, controlled trial.
Inoue Y; Liao W; Wang X; Du X; Tennigkeit F; Sasamoto H; Osakabe T; Hoshii N; Yuen N; Hong Z
Epilepsy Res; 2021 Oct; 176():106705. PubMed ID: 34246118
[TBL] [Abstract][Full Text] [Related]
11. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
[TBL] [Abstract][Full Text] [Related]
12. Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.
Baulac M; Rosenow F; Toledo M; Terada K; Li T; De Backer M; Werhahn KJ; Brock M
Lancet Neurol; 2017 Jan; 16(1):43-54. PubMed ID: 27889312
[TBL] [Abstract][Full Text] [Related]
13. A prospective, multicenter, noninterventional study in Taiwan to evaluate the safety and tolerability of lacosamide as adjunctive therapy for epilepsy in clinical practice.
Wu T; Chuang YC; Huang HC; Lim SN; Hsieh PF; Lee WT; Cheng MY; Tsai MH; Jou SB; Chang CW; Hsieh HY; Du X; Hellot S; McClung C; Hung C
Epilepsy Behav; 2020 Dec; 113():107464. PubMed ID: 33152580
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs.
Neal A; D'Souza W; Hepworth G; Lawn N; Cook M; Nikpour A
Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of adjunctive lacosamide among patients with partial-onset seizures in a long-term open-label extension trial of up to 8 years.
Rosenfeld W; Fountain NB; Kaubrys G; Ben-Menachem E; McShea C; Isojarvi J; Doty P;
Epilepsy Behav; 2014 Dec; 41():164-70. PubMed ID: 25461210
[TBL] [Abstract][Full Text] [Related]
16. Lacosamide for uncontrolled primary generalized tonic-clonic seizures: An open-label pilot study with 59-week extension.
Wechsler RT; Yates SL; Messenheimer J; Leroy R; Beller C; Doty P
Epilepsy Res; 2017 Feb; 130():13-20. PubMed ID: 28086164
[TBL] [Abstract][Full Text] [Related]
17. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial.
Halász P; Kälviäinen R; Mazurkiewicz-Beldzińska M; Rosenow F; Doty P; Hebert D; Sullivan T;
Epilepsia; 2009 Mar; 50(3):443-53. PubMed ID: 19183227
[TBL] [Abstract][Full Text] [Related]
18. Early clinical experience with lacosamide as adjunctive therapy in patients with refractory focal epilepsy and nocturnal seizures.
García-Morales I; Delgado RT; Falip M; Campos D; García ME; Gil-Nagel A
Seizure; 2011 Dec; 20(10):801-4. PubMed ID: 21917484
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of adjunctive lacosamide for the treatment of partial-onset seizures in Chinese and Japanese adults: A randomized, double-blind, placebo-controlled study.
Hong Z; Inoue Y; Liao W; Meng H; Wang X; Wang W; Zhou L; Zhang L; Du X; Tennigkeit F;
Epilepsy Res; 2016 Nov; 127():267-275. PubMed ID: 27669155
[TBL] [Abstract][Full Text] [Related]
20. Lacosamide tolerability in adult patients with partial-onset seizures: Impact of planned reduction and mechanism of action of concomitant antiepileptic drugs.
Foldvary-Schaefer N; Fong JS; Morrison S; Wang L; Bena J
Epilepsy Behav; 2016 Apr; 57(Pt A):155-160. PubMed ID: 26956629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
